ABUS vs HWM · P/E 5.4, rev $180.1M vs P/E 58, rev $4.86B
Arbutus Biopharma Corp (ABUS) versus Howmet Aerospace Inc (HWM) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Howmet Aerospace Inc (HWM) is a aerospace & defense company listed on US.
Latest reported ABUS revenue for 2026-06-30 was $180.1M. Net income was $164.6M. Revenue was up 0.6% from 2026-03-31 to 2026-06-30. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported HWM revenue for 2026-06-30 was $4.86B. Net income was $1.11B. HWM currently screens at market cap $100.79B and trailing P/E 58.4.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. HWM currently screens at market cap $100.79B and trailing P/E 58.4.
Not investment advice. Open the ABUS and HWM stock pages for the full models.
Not investment advice.